Serena Matis

10PUBLICATIONS
36CO-AUTHORS
Predictive and prognostic markersApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer cell biologyMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Jun 26, 2025
Targeting the p53/xCT/GSH Axis with PRIMA-1Met Combined with Sulfasalazine Shows Therapeutic Potential in Chronic Lymphocytic Leukemia.

Martina Pasino, Andrea Speciale, Silvia Ravera

|Jun 26, 2025
The Role of LAIR1 as a Regulatory Receptor of Antitumor Immune Cell Responses and Tumor Cell Growth and Expansion.

Alessandro Poggi, Serena Matis, Chiara Rosa Maria Uras

|Mar 26, 2025
Colorectal Organoids: Models, Imaging, Omics, Therapy, Immunology, and Ethics.

Martina Taglieri, Linda Di Gregorio, Serena Matis

|Jul 13, 2024
Epidermal Growth Factor Receptor Targeting in Colorectal Carcinoma: Antibodies and Patient-Derived Organoids as a Smart Model to Study Therapy Resistance.

Samuele Tardito, Serena Matis, Maria Raffaella Zocchi

|May 24, 2024
Antibody-Drug Conjugate Made of Zoledronic Acid and the Anti-CD30 Brentuximab-Vedotin Exert Anti-Lymphoma and Immunostimulating Effects.

Feliciana Morelli, Serena Matis, Roberto Benelli

|Apr 13, 2024
EGFR-Targeted Antibody-Drug Conjugate to Different Aminobisphosphonates: Direct and Indirect Antitumor Effects on Colorectal Carcinoma Cells.

Leila Pisheh, Serena Matis, Martina Taglieri

Pageof 2

Frequent Collaborators

7 joint publications

Roberto Benelli

6 joint publications

Alessandro Poggi

3 joint publications

Giovanna Cutrona

2 joint publications

Martina Taglieri